| Sign In to gain access to subscriptions and/or personal tools. |
From Venom to Pain Research: A Novel Use of a Scorpaenidae VenomAustralian Centre for Complementary Medicine Education and Research, University of Queensland and Southern Cross University, Lismore NSW, joconnor{at}scu.edu.au
School of Natural and Complementary Medicine, Southern Cross University
Graduate Research College, Southern Cross University The algesic properties of nocitoxina single monomeric, soluble protein responsible for significant algesiawere assessed through human bioassay to gauge nocitoxins potential for use as a clinical pain stimulus. The hypothesis guiding this study stated that subjects tested with crude bullrout venom or nocitoxin will report experience of pain consistent with chemically induced nociception. To test this hypothesis, sterile solutions of crude bullrout venom, nocitoxin, and pooled nonalgesic proteins were applied to the volar aspect of the forearm of human volunteers in a single-blind study. The resultant pain experiences were recorded using a visual analogue scale and a modified version of the McGill pain questionnaire. Data were assessed for significance using multivariate analysis. Pain responses to crude venom and nocitoxin were significantly greater than pain responses to negative controls (visual anologue scale (VAS), P = 0.001; McGill P = 0.01). Bullrout venom and nocitoxin elicit a similar quality and intensity of pain and represent sensitive, measurable, reproducible stimuli in the absence of observable tissue injury. Therefore, nocitoxin may serveas a suitable stimulus for clinical pain research.
Key Words: pain venom human bioassay nocitoxin research pain stimulus
Biological Research For Nursing, Vol. 6, No. 2,
100-109 (2004) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
